Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) New York State Psychiatric Institute |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000270 |
The purpose of this study is to define temporal profile of brain activation (rCBF) using Xenon-SPECT and O 15-PET.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders |
Drug: Cocaine |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Brain Imaging: Cocaine Effects & Medication Development |
Ages Eligible for Study: | 18 Years to 48 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
United States, New York | |
New York State Psychiatric Institute | |
New York, New York, United States, 10032 |
Principal Investigator: | Herbert Kleber, M.D. | New York State Psychiatric Institute |
Study ID Numbers: | NIDA-09236-5, P50-09236-5 |
Study First Received: | September 20, 1999 |
Last Updated: | August 16, 2005 |
ClinicalTrials.gov Identifier: | NCT00000270 |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Dopamine Mental Disorders |
Substance-Related Disorders Disorders of Environmental Origin Cocaine |
Dopamine Uptake Inhibitors Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Cardiovascular Agents |
Pharmacologic Actions Anesthetics, Local Sensory System Agents Therapeutic Uses Vasoconstrictor Agents Dopamine Agents Peripheral Nervous System Agents Central Nervous System Agents |